Xilio To Host Virtual Investor Conference Call And Webcast On Monday, November 6, 2023 To Review Progress Across Pipeline, Including Phase 1/2 Clinical Data For XTX202, A Tumor-Activated, Engineered, Beta-Gamma IL-2, Presented At The SITC Annual Meeting
Benzinga Newsdesk - Oct 31, 2023, 9:22AM